Kraft Heinz 2027 Innovation Pipeline Bets on Protein, Fibre and Low-Sugar Reformulation as GLP-1 Use Reshapes Packaged Food Demand
At its 12 November investor day, Kraft Heinz said nearly half of new products will target health and wellness, with protein versions of Jell-O, Philadelphia and PowerMac, as R&D spend rises toward 0.9% of sales. Management cited GLP-1 use and consumer demand for protein and fibre.








